Just thought I'd revisit this thread, having gone with BUL after the last enquiry (and happily still holding ESG).Anyone got any new preferences for LT CSG plays?
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%